Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results
Appointed director

ROCKET PHARMACEUTICALS, INC. (RCKT) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/10/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/02/2023 4 Makker Gotham (Director) has filed a Form 4 on ROCKET PHARMACEUTICALS, INC.
Txns: Sold 10,312 shares @ $21.0318, valued at $216.9k
Sold 4,677 shares @ $21.1383, valued at $98.9k
10/02/2023 8-K Quarterly results
08/21/2023 4 Patel Kinnari (See Remarks) has filed a Form 4 on ROCKET PHARMACEUTICALS, INC.
Txns: Sold 1,534 shares @ $15.471, valued at $23.7k
08/21/2023 4 Shah Gaurav (CEO) has filed a Form 4 on ROCKET PHARMACEUTICALS, INC.
Txns: Sold 4,767 shares @ $15.471, valued at $73.8k
08/21/2023 4 Militello John (See Remarks) has filed a Form 4 on ROCKET PHARMACEUTICALS, INC.
Txns: Sold 284 shares @ $15.471, valued at $4.4k
08/17/2023 144 Form 144 - Report of proposed sale of securities:
08/17/2023 144 Form 144 - Report of proposed sale of securities:
08/17/2023 144 Form 144 - Report of proposed sale of securities:
08/15/2023 4 Militello John (See Remarks) has filed a Form 4 on ROCKET PHARMACEUTICALS, INC.
Txns: Exercised 725 restricted stock units @ $0
08/15/2023 4 Patel Kinnari (See Remarks) has filed a Form 4 on ROCKET PHARMACEUTICALS, INC.
Txns: Exercised 3,989 restricted stock units @ $0
08/15/2023 4 Shah Gaurav (CEO) has filed a Form 4 on ROCKET PHARMACEUTICALS, INC.
Txns: Exercised 7,979 restricted stock units @ $0
08/09/2023 10-Q Quarterly Report for the period ended June 30, 2023
07/24/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/20/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/20/2023 144 Form 144 - Report of proposed sale of securities:
05/19/2023 4 Shah Gaurav (CEO) has filed a Form 4 on ROCKET PHARMACEUTICALS, INC.
Txns: Sold 4,122 shares @ $21.375, valued at $88.1k
05/19/2023 4 Patel Kinnari (See Remarks) has filed a Form 4 on ROCKET PHARMACEUTICALS, INC.
Txns: Sold 1,330 shares @ $21.375, valued at $28.4k
05/19/2023 4 Militello John (See Remarks) has filed a Form 4 on ROCKET PHARMACEUTICALS, INC.
Txns: Sold 245 shares @ $21.375, valued at $5.2k
05/16/2023 4 Shah Gaurav (CEO) has filed a Form 4 on ROCKET PHARMACEUTICALS, INC.
Txns: Exercised 7,979 restricted stock units @ $0
05/16/2023 4 Militello John (See Remarks) has filed a Form 4 on ROCKET PHARMACEUTICALS, INC.
Txns: Exercised 725 restricted stock units @ $0
05/16/2023 4 Patel Kinnari (See Remarks) has filed a Form 4 on ROCKET PHARMACEUTICALS, INC.
Txns: Exercised 3,989 restricted stock units @ $0
05/09/2023 EFFECT Form EFFECT - Notice of Effectiveness:
05/05/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/01/2023 ARS Form ARS - Annual Report to Security Holders:
04/28/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/28/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
04/25/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/21/2023 144 Form 144 - Report of proposed sale of securities:
04/20/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/06/2023 144 Form 144 - Report of proposed sale of securities:
04/05/2023 POS AM Form POS AM - Post-Effective amendments for registration statement:
04/05/2023 SC 13D/A RTW INVESTMENTS, LP reports a 23% stake in Rocket Pharmaceuticals, Inc.
04/05/2023 4 RTW INVESTMENTS, LP (10% Owner) has filed a Form 4 on ROCKET PHARMACEUTICALS, INC.
Txns: Acquired 529,038 shares @ $0
Acquired 1 options to buy @ $40.0324, valued at $40
Acquired 61,705 warrants @ $65.23, valued at $4M
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy